« Previous
Next »
Titles
- NIH did not consistently meet federal single audit requirements for extramural grants1
- NIH has acted to protect confidential information handled by peer reviewers, but it could do more1
- NIH has made strides in reviewing financial conflicts of interest in extramural research, but could do more1
- National Background Check Program for long-term-care providers: assessment of state programs concluded between 2013 and 20161
- National Background Check Program for long-term-care providers: assessment of state programs concluded in 20191
- National Health Service Corps: report to Congressional requesters1
- National Institutes of Health: Better data will improve understanding of federal contributions to drug development : report to congressional requesters1
- National background check program for long-term-care providers: an interim assessment1
- National biodefense strategy: additional efforts would enhance likelihood of effective implementation : report to Congressional committees1
- Nationwide, almost all Medicaid Managed Care plans achieved their medical loss ratio targets1
- Native Hawaiian health care systems program: services, funding, and oversight : report to congressional committees1
- Nevada Medicaid Fraud Control Unit: 2018 onsite inspection1
- New Jersey could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control1
- New Mexico Medicaid Fraud Control Unit: 2020 review1
- New York did not ensure that a managed care organization complied with requirements for denying prior authorization requests1
- Non-clinical performance assessment of tissue containment systems used during power morcellation procedures: guidance for industry and Food and Drug Administration staff1
- Nonclinical evaluation of the immunotoxic potential of pharmaceuticals: guidance for industry1
- Nontuberculous mycobacterial pulmonary disease caused by mycobacterium avium complex: developing drugs for treatment : guidance for industry1
- Notifying FDA of a permanent discontinuance or interruption in manufacturing of a device under Section 506J of the FD&C Act: guidance for industry and Food and Drug Administration staff1
- Nurse Corps Loan Repayment Program: too early to determine effects of allowing recipients to serve at for-profit facilities : report to Congressional committees1